Geert H Groeneveld
Overview
Explore the profile of Geert H Groeneveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swets M, Kerr S, Mackenna B, Fisher L, van Wijnen M, Brandwagt D, et al.
JMIR Public Health Surveill
. 2025 Jan;
10:e55376.
PMID: 39864403
Background: In March 2022, a concerning rise in cases of unexplained pediatric hepatitis was reported in multiple countries. Cases were defined as acute hepatitis with serum transaminases >500 U/L (aspartate...
2.
Swets M, Niessen A, Buddingh E, Vossen A, Veldkamp K, Veldhuijzen I, et al.
Euro Surveill
. 2024 Jul;
29(27).
PMID: 38967016
BackgroundEffective pandemic preparedness requires robust severe acute respiratory infection (SARI) surveillance. However, identifying SARI patients based on symptoms is time-consuming. Using the number of reverse transcription (RT)-PCR tests or contact...
3.
Weijers J, Prins M, van Dam D, Van Nieuwkoop C, Alsma J, Haak H, et al.
Telemed J E Health
. 2024 Jun;
30(10):2563-2572.
PMID: 38938204
To determine patients' perspectives on home monitoring at emergency department (ED) presentation and shortly after admission and compare these with their physicians' perspectives. Forty Dutch hospitals participated in this prospective...
4.
Swets M, Bakk Z, Westgeest A, Berry K, Cooper G, Sim W, et al.
Clin Infect Dis
. 2024 Jun;
79(5):1153-1161.
PMID: 38916975
Background: Staphylococcus aureus bacteremia (SAB) is a clinically heterogeneous disease. The ability to identify subgroups of patients with shared traits (subphenotypes) is an unmet need to allow patient stratification for...
5.
Drouin N, Elfrink H, Boers S, van Hugten S, Wessels E, de Vries J, et al.
Mol Cell Proteomics
. 2024 Jun;
23(7):100805.
PMID: 38897290
Since its first appearance, severe acute respiratory syndrome coronavirus 2 quickly spread around the world and the lack of adequate PCR testing capacities, especially during the early pandemic, led the...
6.
Swets M, Kerr S, Scott-Brown J, Brown A, Gupta R, Millar J, et al.
Nat Commun
. 2023 Nov;
14(1):7374.
PMID: 37968269
Choosing optimal outcome measures maximizes statistical power, accelerates discovery and improves reliability in early-phase trials. We devised and evaluated a modification to a pragmatic measure of oxygenation function, the [Formula:...
7.
Vollaard A, Slok E, van Dijkman P, Dekkers O, Groeneveld G
Ned Tijdschr Geneeskd
. 2023 Oct;
167.
PMID: 37823884
Influenza infection increases the risk of cardiovascular complications and mortality in patients with heart disease. In patients with coronary artery disease influenza vaccination has been shown to reduce cardiovascular mortality,...
8.
Kingma S, Roukens M, Bosch J, Groeneveld G
Ned Tijdschr Geneeskd
. 2023 Oct;
167.
PMID: 37823868
Increasing complexity due to an ageing population, a shortage of healthcare professionals and the rising costs are major concerns for the acute care in the coming years. Innovative triage methods...
9.
Swets M, Termorshuizen F, de Keizer N, van Paassen J, Palmen M, Visser L, et al.
Ann Thorac Surg
. 2023 Feb;
116(6):1161-1167.
PMID: 36804598
Background: An asymptomatic respiratory viral infection during cardiac surgery could lead to pulmonary complications and increased mortality. For elective surgery, testing for respiratory viral infection before surgery or vaccination could...
10.
Swets M, Moss R, Kor F, Hilarius D, Moes D, Berkhout W, et al.
Int J Infect Dis
. 2023 Feb;
129:57-62.
PMID: 36738957
Objectives: Interleukin (IL)-6 inhibitors are administered to treat patients hospitalized with COVID-19. In 2021, due to shortages, different dosing regimens of tocilizumab, and a switch to sarilumab, were consecutively implemented....